Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01355224 · ClinicalTrials.gov registry record · NA

Communicating Risk Information for Obesity

A NA study of Obesity, sponsored by Boston University.

Completed
Registry status
NA
Development phase
798
Enrollment target
1
Study location

NCT01355224 is a NA study of Obesity that has completed, run by Boston University. The registered enrollment target is 798 participants, roughly in line with the 818-participant average among 1,053 other Obesity trials with a reported enrollment target. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01355224, a NA study of Obesity, has completed, sponsored by Boston University.

COMPLETED
Registry status
NA
Development phase
798 participants
Enrollment target
1
Study location

Study Summary

This study will examine the impact of providing genetic risk information for obesity on people's attitudes and beliefs about obesity, health behaviors and weight outcomes. Specifically, this study will examine the feasibility of using genetic information to motivate efforts to reduce obesity among individuals recruited to the Coriell Personalized Medicine Collaborative (CPMC), see below for description of CPMC.

Conditions Studied

Interventions

  • BEHAVIORAL Lifestyle
  • GENETIC Genetic

Study Locations (1)

New Jersey

  • Coriell Institute for Medical Research - Camden

Trial Details

FieldValue
Enrollment Target 798 participants
Start Date 2011-09
Est. Completion 2013-09
Phase NA

Sponsor

Boston University

185 total trials

What the Registry Record Tells You About NCT01355224

The ClinicalTrials.gov registry entry for NCT01355224 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 798 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 818-participant average among 1,053 other Obesity trials with a reported enrollment target. The listed sponsor is Boston University, which has 185 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Lifestyle is the first listed.

NCT01355224 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.

Frequently Asked Questions

What is clinical trial NCT01355224 about?

NCT01355224 is a clinical study titled "Communicating Risk Information for Obesity". This study will examine the impact of providing genetic risk information for obesity on people's attitudes and beliefs about obesity, health behaviors and weight outcomes. Specifically, this study will examine the feasibility of using genetic information to motivate efforts to reduce obesity among i...

What is the current status of trial NCT01355224?

This trial is currently completed. It is a NA study. The enrollment target is 798 participants. The study started on 2011-09. Estimated completion is 2013-09.

What conditions does trial NCT01355224 study?

This clinical trial studies the following conditions: Obesity.

What interventions are being tested in trial NCT01355224?

The interventions under investigation include: Lifestyle (BEHAVIORAL), Genetic (GENETIC).

Who is sponsoring clinical trial NCT01355224?

This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01355224 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.